NO20063401L - Fremgangsmate for fremstillingen av (3R,3AS,6AR)-heksahydrofuro [2,3-B]furan-3-yl (1S,2R)-3-[[(4-aminofenyl)sulfonyl](isobutyl) amino]-1-benzyl-2-hydroksypropylkarbamat - Google Patents

Fremgangsmate for fremstillingen av (3R,3AS,6AR)-heksahydrofuro [2,3-B]furan-3-yl (1S,2R)-3-[[(4-aminofenyl)sulfonyl](isobutyl) amino]-1-benzyl-2-hydroksypropylkarbamat

Info

Publication number
NO20063401L
NO20063401L NO20063401A NO20063401A NO20063401L NO 20063401 L NO20063401 L NO 20063401L NO 20063401 A NO20063401 A NO 20063401A NO 20063401 A NO20063401 A NO 20063401A NO 20063401 L NO20063401 L NO 20063401L
Authority
NO
Norway
Prior art keywords
amino
isobutyl
hydroxypropylcarbamate
hexahydrofuro
aminophenyl
Prior art date
Application number
NO20063401A
Other languages
English (en)
Other versions
NO337636B1 (no
Inventor
Piet Tom Bert Paul Wigerinck
Nicolaas Martha Feli Goyvaerts
Hartmund Burghard Zinser
Birgit M Ebert
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34740665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063401(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of NO20063401L publication Critical patent/NO20063401L/no
Publication of NO337636B1 publication Critical patent/NO337636B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører en fremgangsmåte for fremstillingen av (3R,3aS,6aR)-heksahydrofuro [2,3-b] furan-3-yl (lS,2R)-3-[[(4-aminofenyl) sulfonyl] (isobutyl) amino]- 1 -benzyl-2-hydroksypropylkarbamat så vel som intermediater for anvendelse i nevnte fremgangsmåte. Mer spesielt vedrører oppfinnelsen fremgangsmåter for fremstillingen av (3R,3aS,6aR)-heksahydrofuro [2,3-b] furan-3-yl (lS,2R)-3-[[(4-aminofenyl) sulfonyll (isobutyl) amino]-l-benzyl-2-hydroksypropylkarbamat som anvender 4-ammo-N-((2R,3S)-3-amino-2-hydroksy-4-fenylbutyl)-N-(isobutyl)benzensulfonamidmtem og to fremgangsmåter mottakelige for industriell opparbeiding. (3R,3aS,6aR)-heksahydrofuro [2,3-b] furan-3-yl (lS,2R)-3-[[(4-aminofényl) sulfonyl] (isobutyl) amino]-l-benzyl-2-hydroksypropylkarbamat er spesielt nyttig som HIV-proteaseinhibitorer.
NO20063401A 2003-12-23 2006-07-21 Fremgangsmåte for fremstillingen av (3R,3aS,6aR)-heksahydrofuro [2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminofenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroksypropylkarbamat NO337636B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03104949 2003-12-23
US56818304P 2004-05-04 2004-05-04
PCT/EP2004/053692 WO2005063770A1 (en) 2003-12-23 2004-12-23 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

Publications (2)

Publication Number Publication Date
NO20063401L true NO20063401L (no) 2006-07-21
NO337636B1 NO337636B1 (no) 2016-05-23

Family

ID=34740665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063401A NO337636B1 (no) 2003-12-23 2006-07-21 Fremgangsmåte for fremstillingen av (3R,3aS,6aR)-heksahydrofuro [2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminofenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroksypropylkarbamat

Country Status (21)

Country Link
EP (1) EP1725566B1 (no)
KR (1) KR101192859B1 (no)
CN (1) CN1898248B (no)
AT (1) ATE433982T1 (no)
AU (1) AU2004309122B2 (no)
BR (1) BRPI0417272B8 (no)
CA (1) CA2549460C (no)
CY (1) CY1109379T1 (no)
DE (1) DE602004021640D1 (no)
DK (1) DK1725566T3 (no)
ES (1) ES2328701T3 (no)
HR (1) HRP20090488T1 (no)
IL (1) IL174960A (no)
MX (1) MXPA06007211A (no)
NO (1) NO337636B1 (no)
PL (1) PL1725566T3 (no)
PT (1) PT1725566E (no)
RU (1) RU2376308C2 (no)
SI (1) SI1725566T1 (no)
WO (1) WO2005063770A1 (no)
ZA (1) ZA200605163B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI432438B (zh) 2005-11-28 2014-04-01 Tibotec Pharm Ltd 作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物及衍生物
CN102432621B (zh) 2006-11-09 2016-02-17 爱尔兰詹森科学公司 六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
WO2008132154A1 (en) 2007-04-27 2008-11-06 Tibotec Pharmaceuticals Ltd. Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
EP2217548A1 (en) * 2007-10-26 2010-08-18 Concert Pharmaceuticals Inc. Deuterated darunavir
TWI482775B (zh) 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
EP2426124B1 (en) * 2009-05-13 2013-08-07 Meiji Seika Pharma Co., Ltd. Process for producing pyripyropene derivative
CA2776807C (en) 2009-09-17 2018-10-16 Mylan Laboratories Limited An improved process for the preparation of darunavir
NZ600994A (en) 2010-01-05 2014-04-30 Cipla Ltd Darunavir polymorph and process for preparation thereof
EP2528923B1 (en) 2010-01-28 2014-07-30 Mapi Pharma Limited Process for the preparation of darunavir and darunavir intermediates
CN102584844B (zh) * 2011-01-11 2016-04-13 浙江九洲药业股份有限公司 一种达芦那韦晶型及其制备方法
EP3795572B1 (en) 2012-07-24 2023-11-15 Laurus Labs Limited Darunavir propionate solvate
CN103893178B (zh) * 2014-03-19 2016-06-01 中山大学 苯-磺酰胺类化合物在制备抗hiv-1病毒药物中的应用
US20160075643A1 (en) * 2014-09-16 2016-03-17 Zcl Chemicals Limited Novel process to prepare intermediates of hiv-protease inhibitors thereof
US10633390B2 (en) * 2015-06-25 2020-04-28 Msn Laboratories Private Limited Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form
ES2881949T3 (es) 2016-10-27 2021-11-30 Gilead Sciences Inc Forma cristalina de base libre de darunavir
CA3041393A1 (en) * 2016-11-17 2018-05-24 Janssen Sciences Ireland Unlimited Company A simplified procedure for the preparation of darunavir
CN114685322B (zh) * 2020-12-30 2023-08-25 上海飞腾医药科技有限公司 一种抗hiv类药物中间体晶体的生长方法和所得晶体及其应用
CN113896658A (zh) * 2021-09-24 2022-01-07 上药康丽（常州）药业有限公司 一种利用微通道反应器合成地瑞那韦中间体的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2210889C (en) 1995-01-20 2007-08-28 G.D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
DE69616446T2 (de) 1995-02-03 2002-05-16 Kaneka Corp., Osaka Verfahren zur herstellung von alpha-haloketonen, alpha-halohydrinen und epoxiden
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
BR9607625A (pt) 1995-03-10 1999-06-15 Searle & Co Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
GB9805898D0 (en) * 1998-03-20 1998-05-13 Glaxo Group Ltd Process for the sythesis of hiv protease inhibitors
AU2322600A (en) 1999-01-29 2000-08-18 Kaneka Corporation Processes for the preparation of (threo)-1,2-epoxy-3-amino-4-phenylbutane derivatives
RU2190614C2 (ru) * 2000-07-11 2002-10-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт "Кристалл" Способ получения 1,4,3,6-диангидро-д-сорбита динитрата
US6764545B2 (en) 2000-12-12 2004-07-20 Ajinomoto Co., Inc. Production method of epoxide crystal
WO2002092595A1 (en) 2001-05-11 2002-11-21 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
EP1466896A4 (en) * 2001-12-28 2005-01-26 Ajinomoto Kk PROCESS FOR PRODUCING A CRYSTAL OF A BENZENESULFONAMIDE DERIVATIVE, AND A NEW CRYSTAL OF AN INTERMEDIATE PRODUCT OF SAID DERIVATIVE AND METHOD FOR PRODUCING THE SAME

Also Published As

Publication number Publication date
ES2328701T3 (es) 2009-11-17
PL1725566T3 (pl) 2009-11-30
NO337636B1 (no) 2016-05-23
CA2549460A1 (en) 2005-07-14
ATE433982T1 (de) 2009-07-15
BRPI0417272A (pt) 2007-03-27
DK1725566T3 (da) 2009-10-05
BRPI0417272B1 (pt) 2020-08-18
IL174960A (en) 2011-06-30
MXPA06007211A (es) 2006-08-18
SI1725566T1 (sl) 2009-12-31
BRPI0417272B8 (pt) 2021-05-25
DE602004021640D1 (de) 2009-07-30
WO2005063770A1 (en) 2005-07-14
ZA200605163B (en) 2007-12-27
EP1725566B1 (en) 2009-06-17
RU2376308C2 (ru) 2009-12-20
AU2004309122B2 (en) 2011-07-21
KR20060123740A (ko) 2006-12-04
CN1898248B (zh) 2011-08-17
EP1725566A1 (en) 2006-11-29
CA2549460C (en) 2014-08-05
KR101192859B1 (ko) 2012-10-19
IL174960A0 (en) 2006-08-20
CY1109379T1 (el) 2014-07-02
CN1898248A (zh) 2007-01-17
PT1725566E (pt) 2009-09-16
HRP20090488T1 (hr) 2009-10-31
RU2006126670A (ru) 2008-01-27
AU2004309122A1 (en) 2005-07-14

Similar Documents

Publication Publication Date Title
CY1109379T1 (el) Διεργασια για την παρασκευη (3r,3αs,6αr)-εξαϋδροφουρο [2,3-β] φουραν-3-υλ (1s,2r)-3-[[(4-αμινοφαινυλ) σουλφονυλ] (ισοβουτυλ) αμινο]-1-βενζυλ-2-υδροξυπροπυλκαρβαμικου
UA85567C2 (en) Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
CY1119311T1 (el) Ψευδο-πολυμορφικες μορφες καταστολεα πρωτεασης hiv
BRPI0212341B8 (pt) compostos intermediários de inibidores de protease de hiv e processo para preparação dos mesmos
SG158888A1 (en) Exo- and diastereo- selective syntheses of himbacine analogs
NO20072288L (no) Sulfonamid pert-substituerte bicykler for okklusly arteriesykdom
ATE516933T1 (de) Rasierergriff und herstellungsverfahren dafür
GT200500257AA (es) Procedimiento para producir derivados de amina opticamente activos
BRPI0408417A (pt) métodos para a produção de um resìduo de gla purificado contendo serina protease, para a purificação de um resìduo de gla contendo serina protease e para estabilização de um resìduo de gla contendo serina protease, e, composição
ATE451370T1 (de) Verbesserte verfahren zur herstellung von n-(ä1,2,4ütriazolopyrimidin-2-yl)arylsulfonamid n
EA200600563A1 (ru) Способ получения рензаприда и его промежуточных соединений
BR112012009956A2 (pt) um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
DE60303865D1 (de) Mannitol- und Glucitolderivate
WO2005000249A3 (en) Preparation of chemical compounds
WO2006102535A3 (en) Sulfonyl containing compounds as cysteine protease inhibitors
NO20061951L (no) Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav
GT200300291A (es) Nuevos compuestos farmaceuticos
ECSP034515A (es) Proceso para producir compuestos quirales
ITPD20040151A1 (it) Inibitori peptidomimetici di proteasi retrovirali e loro uso come antivirali
MX2007003112A (es) Sustancias polimorfas del inhibidor de cisteina-proteasa, n-(1-cianociclopropil)-3-ciclopropilmetanosulfonil-2 (r)-(2,2,2-trifluoro-1(s)-(4-fluorofenil) etilamino)- propionamida.
DE602004005894D1 (de) Verfahren zur herstellung eines gyroskops und konfiguration eines so hergestellten gyroskops
UY27102A1 (es) Formas cristalinas
BRPI0408771A (pt) processo para a produção de imidazopiridin-8-onas
ECSP066998A (es) Derivados quirales de heptina para la preparación de epotilonas y procesos para prepararlos
MY140929A (en) Container structure for lots or chips

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: JANSSEN SCIENCES IRELAND UC, IE